The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Evaluation of the Vascular Anatomy of the Neck to Minimize the Accidental Risk of Vascular Puncture During Percutaneous Tracheostomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06002178
Recruitment Status : Completed
First Posted : August 21, 2023
Last Update Posted : November 18, 2023
Sponsor:
Information provided by (Responsible Party):
Alessandro De Cassai, University of Padova

Tracking Information
First Submitted Date August 15, 2023
First Posted Date August 21, 2023
Last Update Posted Date November 18, 2023
Actual Study Start Date August 14, 2023
Actual Primary Completion Date November 13, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: August 15, 2023)
  • Mapping of artery and veins of the neck in the general population [ Time Frame: through study completion, an average of 1 year ]
    Described as the size of veins and arteries in the neck
  • Size of artery and veins of the neck in the general population [ Time Frame: through study completion, an average of 1 year ]
    Described as the size of veins and arteries in the neck
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Ultrasound Evaluation of the Vascular Anatomy of the Neck to Minimize the Accidental Risk of Vascular Puncture During Percutaneous Tracheostomy
Official Title Ultrasound Evaluation of the Vascular Anatomy of the Neck to Minimize the Accidental Risk of Vascular Puncture During Percutaneous Tracheostomy
Brief Summary

Tracheostomy is a commonly performed procedure in Intensive Care and its incidence tends to increase over time as a consequence of the increase in chronic diseases and the average age of the population accessing Intensive Care.

Surgical open tracheostomy (ST) is the standard procedure but has a relatively high incidence of peristomal infections and perioperative bleeding. Percutaneous dilatational tracheostomy (PDT) was introduced in 1985 and has since become a common bedside procedure. Compared to open ST, PDT has the advantages of a lower risk of wound infection, lower bleeding-related mortality, shorter procedure times, and improved cost-effectiveness.

Fiberoptic bronchoscopy is commonly used during PDT to verify the safety of direct tracheal access [5]. However, bronchoscopy-guided PDT has several limitations regarding the precise identification of cervical anatomical structures and the prevention of complications such as vascular injury.

Preliminary ultrasound examination of neck anatomy has numerous potential benefits, including increased safety during the procedure, identification of cervical vascularization, and localization of the tracheal puncture site with lower risk of complications [6-8]. Several studies have shown that the use of ultrasound in a preliminary and real-time manner can improve first-pass success rate and puncture accuracy, reduce procedure time, and complications.

The objective of this study is to map the arterial and venous vascular anatomy of the neck in order to identify points with a lower risk of vascular injury during PDT. This helps prevent bleeding during tracheostomy, which is one of the major complications associated with the procedure.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population All adult patients accessing the operating room for any reason
Condition
  • Tracheostomy Complication
  • Trachea
Intervention Diagnostic Test: Neck ultrasound
A neck ultrasound will be performed in order to map superficial arteries and veins of the neck
Study Groups/Cohorts Patients undergoing surgical procedure

The following variables will be collected: age, weight, height, gender, previous neck surgery/radiotherapy, previous tracheostomy.

Subsequently, through ultrasound examination, the vascular anatomy of the neck will be studied by dividing it into twelve anatomical quadrants: Four medial quadrants (thyroid membrane, cricoid membrane, and cricothyroid membrane; first tracheal ring, from the beginning of the second tracheal ring to the end of the third tracheal ring), laterally on both right and left sides of each quadrant, the lateral quadrants will be identified. An ultrasound examination with a linear probe with doppler technique will be performed for each quadrant to identify the vascular structures.

For each quadrant, the presence of vessels, arterial or venous nature, and their diameter will be collected.

Intervention: Diagnostic Test: Neck ultrasound
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: August 15, 2023)
500
Original Estimated Enrollment Same as current
Actual Study Completion Date November 13, 2023
Actual Primary Completion Date November 13, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Patients of eighteen years or older
  • Informed consent

Exclusion Criteria:

  • Tracheostomized patients
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers Not Provided
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Italy
Removed Location Countries  
 
Administrative Information
NCT Number NCT06002178
Other Study ID Numbers AOP3019/2023
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Current Responsible Party Alessandro De Cassai, University of Padova
Original Responsible Party Same as current
Current Study Sponsor University of Padova
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators Not Provided
PRS Account University of Padova
Verification Date November 2023